Study Shows Road Taken by Broadly Neutralizing Antibody
By Anette Breindl
Wednesday, April 3, 2013
If current dreams of an AIDS-free generation are to be realized, it will be necessary to develop an effective vaccine against HIV. And such a vaccine will need to induce a broadly neutralizing antibody. About 1 in five HIV-infected individuals ultimately develops such antibodies not that it does them any good. "These antibodies have unusual traits," noted Barton Haynes, of Duke University, and developing those traits takes time.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.